Your browser doesn't support javascript.
loading
Avaliação dos métodos diagnósticos para deficiência de GH (DGH) na infância: IGFs, IGFBPs, testes de liberação, ritmo de GH e exames de imagem: [revisão] / Evaluating diagnosis methods on childhood GH (DGH) deficiency: IGFs, IGFBPs, releasing tests, GH rhythm and image exams: [review]
Paula, Leila Pedroso de; Czepielewski, Mauro A.
  • Paula, Leila Pedroso de; Hospital de Clínicas de Porto Alegre. Porto Alegre. BR
  • Czepielewski, Mauro A; Hospital de Clínicas de Porto Alegre. Porto Alegre. BR
Arq. bras. endocrinol. metab ; 52(5): 734-744, jul. 2008. tab
Article in Portuguese | LILACS | ID: lil-491839
RESUMO
O emprego das diversas metodologias diagnósticas da deficiência de hormônio de crescimento (DGH) em crianças é controverso. Neste artigo serão analisadas estas alternativas revisando a literatura e apresentando dados prospectivos obtidos pelos autores, sugerindo que a DGH seja diagnosticada empregando-se testes de triagem seguidos de testes de confirmação. Assim, recomenda-se que crianças com baixa estatura sejam avaliadas clínica e laboratorialmente para exclusão de doenças crônicas e genéticas. Naquelas com estatura < 3º percentil ou velocidade de crescimento (VC) < percentil 25, dosar IGF-1 como triagem. Se IGF-1 < -1 desvio-padrão (DP), a DGH deve ser confirmada pela ausência de resposta do hormônio de crescimento (GH) a dois testes de estímulo (pico < 5 mcg/L). Em paciente com fatores de risco, IGF-1 < -1 DP e um teste não-responsivo também é diagnóstico de DGH. As crianças com IGF-1 > -1 DP, devem ter a VC acompanhada e, se alterada, pode-se indicar reavaliação do eixo GH/IGF-1 excluindo ou confirmando a DGH.
ABSTRACT
The diagnostic approach to growth hormone deficiency (GHD) in children with short stature (SS) is controversial. Here we review the available methodology and present prospective data obtained in a cohort of patients with SS suggesting the use of screening test followed by the confirmation test. Thus, the children with SS should be submitted to clinical and laboratorial evaluation to exclude of chronic and genetic diseases. In addition patients with height < 3 percentil or growth velocity < percentil 25, IGF-1 levels should be measured. If the IGF1 levels < -1 standard deviation (SD) compared to the age, GHD should be confirmed by two GH-stimulations tests (peak < 5 mcg/L). In risk factor patients, IGF-1 < -1 SD and one non-responsible GH-test, the GHD was confirmed. Children with IGF-1 > -1 SD, the growth velocity should have observed and GH/IGF-1 axis re-evaluated if the growth pattern is not satisfactory.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Insulin-Like Growth Factor I / Mass Screening / Insulin-Like Growth Factor Binding Proteins / Human Growth Hormone / Dwarfism, Pituitary Type of study: Diagnostic study / Prognostic study / Risk factors / Screening study Limits: Child / Humans Language: Portuguese Journal: Arq. bras. endocrinol. metab Journal subject: Endocrinology / Metabolism Year: 2008 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital de Clínicas de Porto Alegre/BR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Insulin-Like Growth Factor I / Mass Screening / Insulin-Like Growth Factor Binding Proteins / Human Growth Hormone / Dwarfism, Pituitary Type of study: Diagnostic study / Prognostic study / Risk factors / Screening study Limits: Child / Humans Language: Portuguese Journal: Arq. bras. endocrinol. metab Journal subject: Endocrinology / Metabolism Year: 2008 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital de Clínicas de Porto Alegre/BR